Dark

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

May 23, 2025 3:59:35 PM EDT

6.95USD-8.793%(-0.67)64,363

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 23, 2025 8:12:30 AM EDT

7.79USD+2.230%(+0.17)203

After-hours

May 23, 2025 4:06:30 PM EDT

6.85USD-1.439%(-0.10)350

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

5.83M

Industry

Biotechnology

Last Split

May 15, 20251for28reverse

RNAZ Stats

Avg. Vol. 10 Day

125,208

Avg. Vol. 30 Day

285,140

Employees

Market Cap

5,826,997

Shares Out.

833,619

On/Off Exchange

31%/69%

6 Month Beta

1.44

1 Year Beta

1.36

2 Year Beta

1.54

3 Year Beta

1.11

52 Week Low

6.15

52 Week High

1,838.76

SMA50

13.01

SMA200

214.89

1 Week

-14.34%

1 Month

-20.50%

3 Month

-96.32%

6 Month

-98.03%

1 Year

-99.46%

2 Year

-100.00%

5 Year

-100.00%

Profile

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.

RNAZ Stock Summary

TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $6.95, and today's volume is 64,363. RNAZ is down -8.793% today. The 30 day average volume is 285,140. RNAZ market cap is 5.83M with 833,619 shares outstanding.

.dark-mode .nggblz{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .nggblz{ color: #333333; background-color: white; border: 2px solid #333333; }RNAZTransCode Therapeutics, Inc. Common Stockstock NASDAQ

RNAZ Stock Summary

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ